Solutions

Clinical solutions

Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions

Consulting & Commercial

Asset Development Consulting Commercial Positioning Language Services Real World Intelligence Regulatory Affairs Symphony Health data

Outcome Measures
COAs and DHTs - measure what matters.

Technologies
Technology solutions from early phase through to post-marketing.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

Embracing a blended operating model
Maximising efficiency and flexibility with custom outsourcing.

De-risking clinical development of precision medicines in oncology
An evolving understanding of cancer biology has resulted in the rise of precision-informed treatment approaches.

Strategies for commercialising oncology treatments for young adults
Oncology treatments tailored specifically for young adults.
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

Webinar: Pregnant participants in clinical trials
17 January 2025

Webinar recording: Unlocking global strategies with proactive regulatory translation manage
Watch the recording
About ICON

About ICON

Company history Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality

ICON for

Patients Volunteers Investigators Jobs & Careers Investors Suppliers

Sustainability, diversity and charity
ICON CARES is our commitment to making a positive impact on our people, environment and our community.

Healthcare Intelligence
Clinical Research. Evolved.

Careers
Investors
Investigators
Patients
Contact

Home
Insights
ICON Webinar Channel

ICON Webinar Channel

Home
Clinical Research Services
Commercialisation & Outcomes
Early Phase
Laboratory Webinars
Medical Device
Therapeutic Webinars

Webinar: Singlicate ADA analysis

36:23

Share on Facebook
Share on X
Share on LinkedIn
Share via Email

Description

Share

Share on Facebook
Share on X
Share on LinkedIn
Share via Email

Related Videos

In Laboratory Webinars

Play video Panel discussion: Immunogenicity assessment of therapeutic proteins

Panel discussion: Immunogenicity assessment of therapeutic proteins

56:37
Play video Panel discussion: ADC bioanalytics

Panel discussion: ADC bioanalytics

55:22
Play video Best practices for the validation of hybrid LC-MS/MS assays

Best practices for the validation of hybrid LC-MS/MS assays

55:01
Play video Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500

Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500

57:36
Play video Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

1:01:13
Play video Webinar: Considerations for Oligonucleotide Therapeutics in CMC

Webinar: Considerations for Oligonucleotide Therapeutics in CMC

1:01:14

Contact
About ICON
Results & Reports

For Clients

Therapeutics
Solutions
Insights
Technologies
Content preferences
Office locations

ICON for

Patients
Volunteers
Investigators
Jobs & Careers
Investors
Suppliers

News & Events

Press releases
Mediakit
Events
Social media dashboard

LinkedIn
Twitter
Facebook
Instagram
Youtube

Disclaimer
Privacy & Data
Cookies

Share this video

Embed

Size: x pixels

Sectors

News & Events

ICON Webinar Channel

Webinar: Singlicate ADA analysis

Share

Related Videos

In Laboratory Webinars

Panel discussion: Immunogenicity assessment of therapeutic proteins

Panel discussion: ADC bioanalytics

Best practices for the validation of hybrid LC-MS/MS assays

Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500

Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

Webinar: Considerations for Oligonucleotide Therapeutics in CMC

Share this video

Embed